TP53 and acute myeloid leukemia: A p53-dependent induction of apoptosis by CK2 inhibition has been already proposed in acute myeloid leukemia [24] and glioblastoma [12, 55], suggesting that p53-null cells are less sensitive to CK2 inhibitors.